SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004623
Filing Date
2021-11-15
Accepted
2021-11-15 16:35:51
Documents
62
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q icvx-20210930.htm   iXBRL 10-Q 2801261
2 EX-10.10 icvx-ex10_10.htm EX-10.10 118492
3 EX-31.1 icvx-ex31_1.htm EX-31.1 18795
4 EX-31.2 icvx-ex31_2.htm EX-31.2 17493
5 EX-32.1 icvx-ex32_1.htm EX-32.1 10182
6 EX-32.2 icvx-ex32_2.htm EX-32.2 10405
  Complete submission text file 0000950170-21-004623.txt   8296554

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT icvx-20210930_pre.xml EX-101.PRE 319980
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT icvx-20210930_lab.xml EX-101.LAB 409091
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT icvx-20210930_cal.xml EX-101.CAL 30220
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT icvx-20210930_def.xml EX-101.DEF 209587
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT icvx-20210930.xsd EX-101.SCH 48037
12 EXTRACTED XBRL INSTANCE DOCUMENT icvx-20210930_htm.xml XML 1216922
Mailing Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102 (206) 737-0085
Icosavax, Inc. (Filer) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40655 | Film No.: 211411521
SIC: 2836 Biological Products, (No Diagnostic Substances)